Journal of Neuroimmunology

Editorial Board
pp. iii-iii(1)

Cytokines and neuro-immune-endocrine interactions: a role for the hypothalamic-pituitary-adrenal revolving axis
pp. 1-19(19)
Authors: Haddad J.J.; Saade N.E.; Safieh-Garabedian B.

IL-4 increases GABAergic phenotype in rat retinal cell cultures: involvement of muscarinic receptors and protein kinase C
pp. 20-29(10)
Authors: Sholl-Franco A.; Marques P.M.B.; Ferreira C.M.C.; de Araujo E.G.

Maternal deprivation of rat pups increases clinical symptoms of experimental autoimmune encephalomyelitis at adult age
pp. 30-38(9)
Authors: Teunis M.A.T.; Heijnen C.J.; Sluyter F.; Bakker J.M.; Van Dam A.-M.M.W.; Hof M.; Cools A.R.; Kavelaars A.

Differential expression of MHC class II and B7 costimulatory molecules by microglia in rodent gliomas
pp. 39-45(7)
Authors: Badie B.; Bartley B.; Schartner J.

TGF-1 upregulates CX3CR1 expression and inhibits fractalkine-stimulated signaling in rat microglia
pp. 46-55(10)
Authors: Chen S.; Luo D.; Streit W.J.; Harrison J.K.

Efficacy of leukemia inhibitory factor in experimental autoimmune neuritis
pp. 56-59(4)
Authors: Laura M.; Gregson N.A.; Curmi Y.; Hughes R.A.C.

Interferon- differentially regulates expression of the IL-12 family members p35, p40, p19 and EBI3 in activated human dendritic cells
pp. 60-71(12)
Authors: van Seventer J.M.; Nagai T.; van Seventer G.A.

Neuroprotection by T-cells depends on their subtype and activation state
pp. 72-80(9)
Authors: Wolf S.A.; Fisher J.; Bechmann I.; Steiner B.; Kwidzinski E.; Nitsch R.

VIP and PACAP down-regulate CXCL10 (IP-10) and up-regulate CCL22 (MDC) in spleen cells
pp. 81-94(14)
Authors: Jiang X.; Jing H.; Ganea D.

Genomic scale profiling of autoimmune inflammation in the central nervous system: the nervous response to inflammation
pp. 95-107(13)
Authors: Carmody R.J.; Hilliard B.; Maguschak K.; Chodosh L.A.; Chen Y.H.

Increased sensitivity to N-methyl-d-aspartate receptor-induced excitotoxicity in cerebellar granule cells from interleukin-1 receptor type I-deficient mice
pp. 108-115(8)
Authors: Pelidou S.-H.; Schultzberg M.; Iverfeldt K.

TWEAK is expressed by glial cells, induces astrocyte proliferation and increases EAE severity
pp. 116-123(8)
Authors: Desplat-Jego S.; Varriale S.; Creidy R.; Terra R.; Bernard D.; Khrestchatisky M.; Izui S.; Chicheportiche Y.; Boucraut J.

⁹-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells
pp. 124-131(8)
Authors: Yuan M.; Kiertscher S.M.; Cheng Q.; Zoumalan R.; Tashkin D.P.; Roth M.D.

Suppression of host resistance to Listeria monocytogenes by acute cold/restraint stress: lack of direct IL-6 involvement
pp. 132-143(12)
Authors: Cao L.; Lawrence D.A.

Stress-related modulation of matrix metalloproteinase expression
pp. 144-150(7)
Authors: Yang E.V.; Bane C.M.; MacCallum R.C.; Kiecolt-Glaser J.K.; Malarkey W.B.; Glaser R.

Clinical and MRI disease activity in multiple sclerosis are associated with reciprocal fluctuations in serum and cerebrospinal fluid levels of soluble HLA class I molecules
pp. 151-159(9)
Authors: Fainardi E.; Granieri E.; Tola M.R.; Melchiorri L.; Vaghi L.; Rizzo R.; Castellazzi M.; Ceruti S.; Paolino E.; Baricordi O.R.

Molecular mechanisms underlying cyclic AMP inhibition of macrophage dependent TNF- production and neurotoxicity in response to amyloidogenic C-terminal fragment of Alzheimer's amyloid precursor protein
pp. 160-174(15)
Authors: Chong Y.H.; Shin S.A.; Lee H.J.; Kang J.H.L.; Suh Y.-H.

Analysis of immunoregulatory T-helper cell subsets in patients with multiple sclerosis: relapsing-progressive course correlates with enhanced T_H1, relapsing-remitting course with enhanced T_H0 reactivity
pp. 175-183(9)
Authors: Barth H.; Klein K.; Bortlein A.; Guseo A.; Berg P.A.; Wietholter H.; Klein R.

Chemokine receptors associated with immunity within and outside the central nervous system in early relapsing-remitting multiple sclerosis
pp. 184-192(9)
Authors: Wang H.-Y.; Matsui M.; Araya S.-i.; Onai N.; Matsushima K.; Saida T.

The macrophage activity marker sCD14 is increased in patients with multiple sclerosis and upregulated by interferon beta-1b
pp. 193-197(5)
Authors: Brettschneider J.; Ecker D.; Bitsch A.; Bahner D.; Bogumil T.; Dressel A.; Elitok E.; Kitze B.; Poser S.; Weber F.; Tumani H.

Evidence for heterogeneity of T cell expansion in polymyositis and inclusion body myositis
pp. 198-204(7)
Authors: van der Meulen M.F.G.; van Wichen D.F.; van Blokland W.T.M.; van den Berg L.H.; Wokke J.H.J.; Hoogendijk J.E.; de Weger R.A.

Expression of CD5 on B lymphocytes correlates with disease activity in patients with multiple sclerosis
pp. 205-210(6)
Authors: Seidi O.A.; Semra Y.K.; Sharief M.K.

The apoptotic effect of somatostatin analogue SMS 201-995 on human lymphocytes
pp. 211-216(6)
Authors: Lattuada D.; Casnici C.; Venuto A.; Marelli O.

Baseline T cell reactivity in multiple sclerosis is correlated to efficacy of interferon-
pp. 217-224(8)
Authors: Killestein J.; Hintzen R.Q.; Uitdehaag B.M.J.; Baars P.A.; Roos M.T.; van Lier R.A.W.; Polman C.H.

Chemokine receptor expression on T cells is related to new lesion development in multiple sclerosis
pp. 225-232(8)
Authors: Eikelenboom M.J.; Killestein J.; Izeboud T.; Kalkers N.F.; van Lier R.A.W.; Barkhof F.; Uitdehaag B.M.J.; Polman C.H.

Catecholamine production and tyrosine hydroxylase expression in peripheral blood mononuclear cells from multiple sclerosis patients: effect of cell stimulation and possible relevance for activation-induced apoptosis
pp. 233-240(8)
Authors: Cosentino M.; Zaffaroni M.; Marino F.; Bombelli R.; Ferrari M.; Rasini E.; Lecchini S.; Ghezzi A.; Frigo G.

Myelin oligodendrocyte glycoprotein polymorphisms and multiple sclerosis
pp. 241-243(3)
Authors: Gomez-Lira M.; Moretto G.; Bonamini D.; Benedetti M.D.; Pignatti P.F.; Rizzuto N.; Salviati A.

Author index of volume 133
pp. 244-246(3)

Subject index of volume 133
pp. 247-251(5)